QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LNTH

QT82Lantheus Holdings, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
103.86
+0.67+0.65%
OverviewShort InterestFilings
LNTHQT82Lantheus Holdings, Inc.·NASDAQ
OverviewShort InterestFilings
103.86+0.65%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01AMRX-0.43%$16.21
Snapshot
Index-P/E23.94EPS (ttm)4.15
Insider Own24.66%
Shs Outstand65.11M
Perf Week-0.44%
Market Cap6.72BForward P/E16.27EPS next Y6.38Insider Trans0.00%Shs Float-Perf Month11.81%
Enterprise Value6.85BPEG1.66EPS next Q1.31Inst Own-Short Float-Perf Quarter33.17%
Income280.82MP/S4.35EPS this Y28.90%Inst Trans-Short Ratio-Perf Half Y59.37%
Sales1.55BP/B5.51EPS next Y19.30%ROA11.89%Short Interest-Perf YTD56.06%
Book/sh18.61P/C16.38EPS next 5Y12.59%ROE24.33%52W High107.99 -3.82%Perf Year33.29%
Cash/sh7.66P/FCF18.07EPS past 3/5Y-ROIC10.75%52W Low47.25 119.81%Perf 3Y-
Dividend Est.-EV/EBITDA14.48Sales past 3/5Y18.15% 35.39%Gross Margin60.48%Volatility2.06% 2.54%Perf 5Y-
Dividend TTM-EV/Sales4.43EPS Y/Y TTM36.93%Oper. Margin18.76%ATR (14)3.38Perf 10Y-
Dividend Ex-Date-Quick Ratio2.64Sales Y/Y TTM0.78%Profit Margin18.05%RSI (14)63.29Recom2.50
Dividend Gr. 3/5Y-Current Ratio2.83EPS Q/Q-4.58%SMA202.89%Beta0.51Target Price108.50
Payout0.00%Debt/Eq0.52Sales Q/Q1.07%SMA5012.05%Rel Volume1.14Prev Close103.19
Employees808LT Debt/Eq0.57EarningsAug 05SMA20046.56%Avg Volume955.07KPrice103.86
IPO DateJun 25, 2015Option/ShortYes / YesEPS/Sales Surpr.16.80% 6.50%Net Debt/EBITDA0.27Volume1,090,747Change0.65%
Analyst Ratings
DateActionAnalystRatingTarget
May-27-26ReiteratedMizuho Securities$100 → $115
May-11-26ReiteratedTruist Financial$98 → $115
May-07-26ReiteratedGoldman SachsNeutral$82 → $94
Apr-15-26ReiteratedTruist Financial$89 → $98
Apr-13-26ReiteratedMizuho Securities$85 → $95
Mar-17-26ReiteratedJefferiesBuy$110
Feb-27-26ReiteratedTruist Financial$82 → $89
Feb-27-26DowngradeJones TradingBuy → Hold
Dec-18-25ReiteratedTruist Financial$80 → $82
Dec-17-25ReiteratedMizuho Securities$60 → $72
Latest News
Jun-12-26
Jun-12-2609:58AM
3 Healthcare Stocks with Open QuestionsYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,5461,5421,534
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A611600546
Gross Profit935942988
Selling, General and Administrative Excl. Other465454372
Research and Development179177168
Other Operating Expense20-9
Operating Income290311457
Interest Expense202020
Unusual Expense
———
Non-Operating Income (Expense)-103-236
Net Income Before Taxes373314431
Income Taxes9580119
Consolidated Net Income279234312
Net Income From Continuing Operations279234312
Net Income279234312
EPS (Recurring)4.213.464.52
EPS (Basic, Before Extraordinaries)4.213.464.52
EPS (Diluted)4.153.414.36
EBITDA473404515
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio25.0319.52—
Price To Sales Ratio4.372.89—
Gross Margin60.4861.0964.41
Operating Margin18.7620.1729.79
Net Margin18.0515.1820.34
Shares Outstanding656769
Market Capitalization6,7514,459—
Operating Lease Expense
———
Insider Trading Volume
$106.80$101.73$96.65$91.57$86.50● Close Price0.00M95.65M191.30M286.94M382.59MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
PATEL RAJIV Aother: Member of a Group Owning 10%Aug 20 '25Sale56.153,365,000188,944,7503,477,227Aug 21 12:00 AM
FARALLON PARTNERS L L C/CA10 percent owner, other: Member of a Group Owning 10%Aug 20 '25Sale56.153,365,000188,944,7503,477,227Aug 21 12:00 AM
FARALLON PARTNERS L L C/CA10 percent owner, other: Member of a Group Owning 10%Aug 19 '25Sale55.3441,0002,268,9406,842,227Aug 21 12:00 AM
PATEL RAJIV Aother: Member of a Group Owning 10%Aug 19 '25Sale55.3441,0002,268,9406,842,227Aug 21 12:00 AM
Blanchfield PaulPresidentAug 13 '25Sale53.573,060163,924108,214Aug 15 12:00 AM
Niedzwiecki DanielSee RemarksJun 13 '25Sale78.746,000472,44087,057Jun 17 12:00 AM
Marshall Robert J. Jr.CFO and TreasurerJun 09 '25Option Exercise49.9329,5461,475,232128,633Jun 11 12:00 AM
Marshall Robert J. Jr.CFO and TreasurerJun 09 '25Sale83.0039,7733,301,29688,860Jun 11 12:00 AM
McHugh JulieDirectorJun 09 '25Sale81.625,192423,77125,962Jun 11 12:00 AM
Blanchfield PaulPresidentJun 05 '25Sale79.656,599525,610111,792Jun 09 12:00 AM
Niedzwiecki DanielSee RemarksJun 05 '25Sale79.656,000477,90093,057Jun 09 12:00 AM
Heino Mary AnneDirectorJun 02 '25Sale76.8326,0662,002,570318,650Jun 04 12:00 AM
Marshall Robert J. Jr.CFO and TreasurerMar 17 '25Sale100.5210,0001,005,200113,860Mar 19 12:00 AM
Heino Mary AnneDirectorMar 13 '25Sale100.1322008,618Mar 17 12:00 AM
Heino Mary AnneDirectorJun 07 '24Sale81.2618137,719Mar 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR